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ABSTRACT 
 
Background: The seladin-1 (selective Alzheimer disease indicator-1), also known as DHCR24, is a gene found to 
be down-regulated in brain region affected by Alzheimer disease (AD). Whereas, hair follicle stem cells (HFSC), 
which are affected in with neurogenic potential, it might to hypothesize that this multipotent cell compartment is 
the predominant source of seladin-1. Our aim was to evaluate seladin-1 gene expression in hair follicle stem cells. 
Methods: In this study, bulge area of male Wistar rat HFSC  were cultured and then characterized with Seladin-1 
immunocytochemistry and flow cytometry on days 8 to 14. Next, 9-11-day cells were evaluated for seladin-1 gene 
expression by real-time PCR. Results: Our results indicated that expression of the seladin-1 gene (DHCR24) on 
days 9, 10, and 11 may contribute to the development of HFSC. However, the expression of this gene on day 11 
was more than day 10 and on 10th day was more than day 9. Also, we assessed HFSC on day 14 and demonstrated 
these cells were positive for β-ш tubulin, and seladin-1 was not expressed in this day. Conclusion: HFSC express 
seladin-1 and this result demonstrates that these cells might be used to cell therapy for AD in future. Iran. Biomed. 
J. 18 (3): 136-142, 2014 
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INTRODUCTION 
 
lzheimer disease (AD) is a progressive neuro-
degenerative disease characterized clinically 
by insidious onset of memory and cognition 
deterioration as well as daily activity impairment. The 
neurodegenerative process in AD may involve in β-
amyloid toxicity [1]. 
During the past decade, many hypotheses were put 
forward for AD pathogenesis. Among them, the β-
amyloid cascade and the tau hyperphosphorylation are 
the widely accepted theories. Therefore, the disease-
modifying therapies mainly focus on the agents that 
decrease the Aβ content and tau hyperphosphorylation 
[2, 3]. 
The seladin-1 (selective Alzheimer disease indicator-
1) gene was first identified in 2000 by using a 
differential mRNA display approach. This approach 
was applied to identify the genes that were 
differentially expressed in selective vulnerable brain 
regions in AD [4], such as hippocampus, amygdala, 
inferior temporal cortex, and the entorhinal cortex [3]. 
A few years ago, a novel gene, named seladin-1 or 
DHCR24, was identified that was associated with 
neurodegeneration. In fact, this gene was found to be 
down-regulated in brain regions affected by AD [4, 5]. 
Down-regulation of seladin-1 expression in brain areas 
vulnerable to AD was paralleled by an increase in the 
amount of hyperphosphorylated tau, a protein 
component of neurofibrillary tangles [6]. 
With regard to its biological effects, seladin-1 was 
originally found to confer resistance against β-amyloid 
and oxidative stress-induced apoptosis [5, 7]. It has 
been also demonstrated that the ability of seladin-1 to 
protect against the apoptosis elicited by oxidative stress 
may be related to the scavenging activity of this protein 
[8]. However, this ability of seladin-1 was associated 
with high H2O2-scavening activity, whereas an N-
A
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terminal deletion caused loss of this activity. 
Furthermore, seladin-1 effectively inhibited the 
activation of caspase-3, a key mediator of the apoptotic 
process [5, 7]. In fact, reduced seladin-1 levels 
prevented apoptosis in a p53-dependent manner via 
increased ubiquitination and degradation of p53, a 
protein with enzymatic activity [9]. 
It has been shown that the seladin-1 gene encodes 
3β-hydroxysterol Δ24-reductase, which catalyzes the 
synthesis of cholesterol from desmosterol [10, 2]. 
Disruption of cholesterol homeostasis may be 
detrimental for cells, because cholesterol-depleted 
membrane would easily interact with toxic factors such 
as β-amyloid, the histopathological hallmark of AD 
[11, 12]. 
The seladin-1 gene (Gene Bank accession number 
AF261758) spans 46.4 kb, maps to chromosome 
1p31.1-p33 and consists of nine exons and eight 
introns. This gene encodes an open reading frame of 
516 amino acid residues and is located in the 
endoplasmic reticulum and, to a lesser extent, in the 
Golgi apparatus [4]. Also, seladin-1 is the human 
homolog of the plant DIMINUTO/DWARFI gene, 
primarily described in Arabidopsis thaliana [13, 14]. 
Hippocampus and the sub-ventricular zone are two 
areas in brain that are affected in AD [2]. Interestingly, 
these areas are the unique regions where stem cells 
with a defined neurogenic potential are located in the 
adult brain [15]. In fact, although neural stem cells are 
present in many other areas of the adult brain, they do 
not appear to maintain the ability of differentiation into 
neurons [15]. 
Epidermal neural crest stem cells (EPI-NCSC) are 
multipotent stem cells derived from the embryonic 
neural crests which reside in the bulge of the outer root 
sheath of the adult murine hair follicles [16]. EPI-
NCSC can be isolated as a highly pure population, 
generate all major neural crest derivatives, and be 
expanded in vitro into millions of cells [17, 18]. Toma 
et al. [19] reported that multipotent adult stem cells 
isolated from mammalian skin dermis, termed skin-
derived precursors, could proliferate and differentiate 
into culture media and produce neurons, glia, smooth 
muscle cells, and adipocytes. In addition, intermediated 
filament protein nestin, a marker of immature and 
undifferentiated cell [20] was expressed in some cells 
in the bulge area of the hair follicle [21, 22]. 
In this study, we aimed to assess whether hair follicle 
stem cells (HFSC) could express the seladin-1 gene. 
Since the seladin-1 expression is reduced in AD, stem 
cells might be the prevalent sources of this protein. 
 
 
MATERIALS AND METHODS 
 
Media. Cells were maintained in a 95% air and 5% 
CO2 fully humidified environment at 37°C in a culture 
medium consisted of three parts DMEM and one part 
Ham’s F12 medium containing 10% fetal bovine 
serum, 100 U/mL penicillin, 100 μg/mL streptomycin, 
0.5 µg/ml amphotericin B, 10 ng/mL epidermal growth 
factor (Sigma-Aldrich, CA, USA), 10-9M cholera toxin 
(Sigma-Aldrich, CA, USA), 0.5 mg/mL hydro-
cortisone, and 5 µg/mL insulin [23]. 
 
Hair follicle isolation and cultivation. The selected 
rats were sacrificed with ether, their heads were rinsed 
with 70% alcohol and disinfected with betadine, and 
their cheeks were then maintained. After that, the 
whisker area tissue was separated and incubated in 2 
mg/mL collagenase I/dispase II solution (Sigma-
Aldrich, CA, USA) at 37°C for 15 minutes. The 
connective tissue and the dermis around the follicles 
were removed, and the whisker follicle was lifted out. 
Next, the bulges were removed from the capsule and 
placed in collagen-coated culture flasks. They stack to 
the bottom of flask within one day. Three to four days 
after the cell adhesion, the cells started to emigrate 
from the bulge explants to the other sides of the flask 
bottom [24, 25]. 
 
Immunocytochemistry. Ten days after the cell 
culture, HFSC were plated in collagen-coated plates 
with 24 chambers in a growth medium overnight. The 
cells were then fixed in 4% paraformaldehyde for 20 
minutes. Next, the fixed cells were washed three times 
with PBS for five minutes and incubated in a blocking 
buffer (10% goat serum, Sigma [CA, USA] and 0.3% 
Triton X-100, Fluka, CA, USA) at room temperature 
for 30 minutes. They were then incubated at 4°C 
overnight with the following primary antibodies: 
mouse anti-nestin monoclonal antibody (1:200, 
Millipore, MA, USA), mouse anti-CD34 monoclonal 
antibody (1:200, Sigma, CA, USA), mouse anti-
KRT15 monoclonal antibody (1:1700, Sigma, CA, 
USA), mouse monoclonal anti-βШ tubulin antibody 
(1:400, Sigma-Aldrich, CA, USA), and mouse 
monoclonal [sL-14] to seladin-1 (1:25, Abcam, CA, 
USA). The next day, the cells were washed three times 
with PBS for five minutes to remove the unbound 
primary antibodies. Subsequently, they were incubated 
with sheep anti-mouse FITC-conjugated IgG (1-200, 
Sigma, CA, USA) at room temperature for 1 hour and 
rinsed with PBS for 3 × 5 minutes. Then, the cell 
nuclei were counterstained with 1 µg/mL diamino-2-
phenylindole and visualized using a fluorescence 
microscope. 
 
Flow cytometry. After separating from the bottom of 
the flask, the cells were centrifuged and 1 mL of the 
culture media was added to the cellular plaque. The 
cells were then counted and divided into two groups 
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(main and control). In the next step, the main group 
was centrifuged, and the following primary antibodies 
were added to the cellular plaque: mouse anti-nestin 
monoclonal antibody (1:200, Millipore, MA, USA), 
mouse anti-CD34 monoclonal antibody (1:200, Sigma, 
CA, USA), mouse anti-KRT15 monoclonal antibody 
(1:1700, Sigma, CA, USA), and mouse monoclonal 
[sL-14] to seladin-1(1:25, Abcam, CA, USA). Finally, 
the mixture was kept at room temperature for 1 hour. 
After that, 2 mL phosphate buffer was added to the 
main group, then it was centrifuged. Next, FITC-
conjugated IgG (1:200; Sigma, CA, USA) was inserted 
to the cellular plaque tube, and the final mixture was 
incubated for 45 minutes at room temperature. Then, 2 
mL of PB was added to each of the two cellular 
groups, and they were centrifuged. Finally, 1 mL of PB 
was added to the cellular plaques, and the suspension 
was poured into flow cytometry tubes. Absolute 
quantification of DHCR24 mRNA was performed by 
real-time PCR (RT-PCR) based on TaqMan techno-
logies, as described previously [26]. The total RNA to 
be subjected to reverse transcription was extracted 
from fetal neuroepithelial cells in the basal condition 
and after exposure to insulin-like growth factor 1 or 
high glucose concentrations. The results were referred 
to as microgram of total RNA, and the experiments (n 
= 3) were run in triplicates. 
 
Quantitative real time PCR for the seladin-1 
transcript. Measurement of the seladin-1 transcript was 
performed by quantitative RT-PCR based on SYBR® 
Green technology (Qiagen, Germany). The total RNA 
was extracted from the cells previously lysed using 
RNX-PLUS (CinnaGen, Iran). The measurement of 
RNA purity was performed by a spectrophotometer, 
then cDNA was constructed, and the primers were 
prepared. The primers used for the seladin-1 gene were  
as follows: 5'CATCGTCCCACAAGTATG 3' 
(forward) and 3'CTCTACGTCGTCCGTCA 5' 
(reverse). The primers were designed using primer 3 
software and then analyzed and verified using Oligo7 
software. Quantitative reverse transcription was 
performed in three steps: 95°C for 10 minutes, 35 
cycles at 95°C for 15 seconds and at 60°C for 30 
seconds. Finally, the melting curve was assessed at 60-
95°C. Also, the housekeeping gene, GAPDH, was used 
as the reference gene. Then, three experiments were 
performed; each of which was run in triplicates. Gene 
expression was evaluated by the relative approach 
using the relative expression software tool (REST). 
 
Statistical analysis. The data were expressed as 
mean ± SEM. Statistical differences were analyzed to 
be appropriate using student’s t-test. P<0.05 was 
considered statistically significant. 
 
 
RESULTS 
 
Characterization of hair follicle stem cells. HFSC 
were successfully cultured and propagated in vitro, and 
homogeneous population of stem cells covered the 
bottom of the cell cultured flask after 10 days (Fig. 1). 
Fluorescent cell sorting at passage 1 demonstrated that 
the cultured cells had neural crest characteristic, 
because they were positive for nestin (neuron 
progenitor cell marker) and CD34 (stem cell specific 
marker) and negative for K15 (keratinocyte cell 
marker) antibodies (Fig. 2). The immunostaining 
results of 14-day HFSC with β-III tubulin (neuron-like 
marker) were positive, showing that EPI-NCSC can 
differentiate into neuron on a collagen-coated flask 
after 14 days (Fig. 3). After that, the flow cytometry 
analysis was used to assess the purity of HFSC cultures 
with nestin, CD34, and K15 antibodies (Fig. 4). 
 
 
 
 
 
Fig. 1. Characteristics of hair follicle stem cell (HFSC) cultures shown by inverted microscopy. The migratory cells are present on 
the collagen substratum. (A) HFSC one day after the primary culture, (B) migration of HFSC after the colony formation, (C) HFSC 
proliferation, and (D) HFSC culture after 10 days (Scale bar = 20 µm). 
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Fig. 2. Immunocytochemical detection of nestin, CD34, and K15 antibodies in rat hair follicle stem cell. (A) nestin-positive cells, 
(B) CD34-positive cells, and (C) K15-negative cells. The nuclei were counterstained with 4',6'-diamidino-2-phenylindole (Scale bar = 
50 µm). 
 
 
Assessment of the seladin-1 gene expression in hair 
follicle stem cells. The expression of seladin-1 gene 
was shown using immunocytochemistry (Fig. 5), and 
its expression level was evaluated by RT-PCR (Fig. 3). 
The immunocytochemistry study demonstrated that 
HFSC can express seladin-1, but when these cells 
differentiate into the neurons, they cannot express this 
gene (Figs. 5 and 6). In fact, after confirming the 
presence of this gene in 9-11-day cells with 
immunocytochemistry, RT-PCR was used to compare 
the gene expression during these three days. The 
results of RT-PCR showed that the seladin-1 gene had 
less expression in 9-day cells and extreme expression 
in 11-day cells. In the sample group, 9-11-day cells 
were different compared with the control group (P = 
0.000). However, 10-11-day cells were down-regulated 
by a mean of 0.061 compared with the control group. 
In this group, 10-11-day cells were also different 
compared with the control group (P = 0.045). 
      
 
 
 
Fig. 3. Amount of seladin-1 mRNA in hair follicle stem cells, 
determined by RT-PCR. The boxes represent the interquartile 
range. The dotted lines represent the medium gene expression. 
Box plots represent the minimum and maximum observations. 
 
 
 
 
 
 
 
Fig. 4. Flow cytometric analysis of the surface adhesion molecules on hair follicle stem cell (HFSC). Cultured HFSC were labeled 
with monoclonal antibodies specific for molecules indicated in each flow cytometric histogram.  (A) Positive for nestin antibody, (B) 
positive for CD34 antibody, and (C) negative for K15. 
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Fig. 5. Immunocytochemical detection of the seladin-1 gene expression in rat hair follicle stem cell. (A) Immunostained cells with 
4',6'-diamidino-2-phenylindole (DAPI) from the 10-day cells, (B) bulge cells on day 10 expressed seladin-1, (C) immunostained cells 
with DAPI from14-day cells, and (D) bulge cells on days 14 did not express seladin-1 (Scale bar = 20 µm). 
 
 
DISCUSSION 
 
In the present study, we investigated the seladin-1 
gene expression in a cell culture. The seladin-1 gene 
discovery as well as finding out that its expression is 
down-regulated in the brain areas affected by AD, the 
most prevalent form of late-life mental failure in 
humans, have opened a new window for understanding 
the associated neurodegenerative molecular events [4, 
27]. 
The aim of our study was to investigate the 
evaluation of seladin-1 gene expression in HFSC. 
Possibly, the seladin-1 gene expression can be 
impaired in vulnerable areas to AD. In addition, 
neurogenic potential of some of these regions, 
including the hippocampus and the sub-ventricular 
zone of the host stem cells as well as their ability to 
migrate in the adult brain [15], led us to the hypothesis 
that this gene can also be expressed in other neuronal 
stem cells. 
Siber-Blum et al. [16] described NCSC in the bulge 
area of the adult murine whisker follicles and 
introduced these cells as EPI-NCSC. According to 
Amoh et al. [28] investigation, nestin-positive K15-
negative stem cells in the mouse hair follicles are 
multipotent and can differentiate into neurons, glial 
cells, keratinocytes, and other cell types. Therefore, we 
used HFSC of the mouse whisker hair follicles as 
neuronal stem cells. Furthermore, investigation of the 
bulge cell biology and use of bulge cells for clinical 
applications such as regenerative medicine or gene 
therapy require the isolation of living bulge cells [29]. 
In addition, some factors make the bulge cell a perfect 
stem cell; it may even be the stem cell of choice in 
regenerative medicine in future. For example, it is 
readily available from anyone, easily cultured and 
expanded, and does not have the ethical issues of 
embryonic and fetal stem cells. All of these benefits 
eventually led us to select this cell line for assessment 
of the seladin-1 gene expression [30]. 
 
 
 
Fig. 6. Immunocytostaining of epidermal neural crest stem 
cell (EPI-NCSC) of the bulge region of hair follicle stem cell 
after 14 days. Expression of the neuron-like marker (β-III 
tubulin) with EPI-NCSC. The nuclei were counterstained with 
4',6'-diamidino-2-phenylindole (Scale bar = 100 µm). 
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The results of our study showed that the seladin-1 
gene was expressed in HFSC. According to the fact 
that defective seladin-1 gene expression is detected in 
AD vulnerable brain regions, it might be linked to an 
impaired neuronal stem cell compartment that could be 
a potential risk factor for this disease [3, 4]. Based on 
Greeve et al. [4] findings, the high levels of seladin-1 
gene mRNA transcription were detected in the adult 
hippocampus, a well-known neurogenic brain region. 
Our findings depicted that the seladin-1 mRNA 
transcription in HFSC, which are a type of NCSC, is of 
high importance. The finding in mice bulge cells 
suggested the hypothesis that stem cells are rich in 
bulge areas. Our results of rat hair follicle bulge area 
culture also supported this hypothesis [31]. 
Morphology-based manual microdissection was used 
to isolate the bulge cells from the hair follicle [32, 33]. 
The method of isolation was based on the migration of 
cells from the cultured bulge region.  
These pluripotent nestin-expressing stem cells were 
positive for the stem cell marker CD34 and negative 
for K15, suggesting that these cells are in a relatively 
undifferentiated state [26, 34, 35]. The nestin-
expressing stem cells by immunocytochemistry and 
flow cytometry also indicated that the seladin-1 gene 
was expressed in HFSC, when they were 
morphologically identical to neural stem cells, and 
when these cells were differentiated into neurons. As a 
result, we could not detect the seladin-1 gene 
expression, as mentioned by Benvenuti et al. [36]. 
They stated that this gene was abundantly expressed in 
stem cells, whereas the level of expression was 
markedly decreased when these cells were induced to 
differentiate into mature neurons. Therefore, their 
demonstration of seladin-1 gene was limited and 
variable, and when expressed, their levels were low. 
Therefore, we decided to measure the expression of 
this gene on days 9, 10, and 11 using RT-PCR.  
Interestingly, we found that the expression of this 
gene on day 11 was more than day 10 and on day 10 
more than day 9, which was opposite to our 
expectation. Probably, the reason was that this gene 
was expressed in HFSC when the stem cell 
differentiated into neuron. Perhaps, the stem cells have 
some indices of neural cells then do not differentiate 
into neuron. On the other hand, this gene might be 
expressed in a specific age of stem cells. Presumably, 
its expression elevates prior to differentiation and stops 
after that. As observed in the 14-day cells, the 
expression of this gene stopped. The expression of 
seladin-1 gene in HFSC might be revealed in future. 
These cells can be used in cell therapy for AD. 
In conclusion, our results indicated, for the first time, 
that expression of the seladin-1 gene (DHCR24) on 
days 9, 10, and 11 may contribute to the development 
of HFSC to neurons, by interfering with the trophic 
effects exerted by the epidermal growth factor system. 
It also suggested the involvement of prosurvival effect 
of DHCR24 as a factor. Nevertheless, additional 
studies, i.e. subjecting the cells to DHCR24 gene 
silencing factors, are required to clarify the exact role 
of DHCR24 in mediating the agents affecting the 
neuron cell differentiation. 
 
 
ACKNOWLEDGEMENTS 
 
This research was supported by a grant (No. 
89000433) from Iran National Science Foundation 
(INSF), Tehran. The authors would like to thank the 
Anatomy Department, Medical School, Iran University 
of Medical Science (Tehran) for their cooperation. 
 
 
REFERENCES 
 
1. Nobakht M, Hoseini SM, Mortazavi P, Sohrabi I, 
Esmailzade B, Rahbar Rooshandel N, et al. 
Neuropathological changes in brain cortex and 
hippocampus in a rat model of Alzheimer’s disease. 
Iran Biomed J. 2011; 15(1-2):51-8. 
2. Hong-Qi Y, Zhi-Kun S, Sheng-Di C. Current advances 
in the treatment of Alzheimer's disease: focused on 
consideration targeting Aβ AND tau. Transl 
Neurodegener. 2012 Oct; 1(1):21. 
3. Selkoe DJ. Alzheimer's disease: genes, proteins, and 
therapy. Physiol Rev. 2001 Apr; 81(2):741-66. 
4. Greeve I,  Hermans-Borgmeyer I,  Brellinger C,  Kasper 
D,  Gomez-Isla T,  Behl C,  et al. The human 
DIMINUTO/DWARF1 homolog seladin-1 confers 
resistance to Alzheimer’s disease-associated 
neurodegeneration and oxidative stress. J. Neurosci. 
2000 Oct; 20(19):7345-52. 
5. Pedretti A, Bocci E, Maggi R, Vistoli G.  Homology 
modeling of human DHCR24 (Seladin-1) and analysis 
of its binding properties through molecular docking and 
dynamics simulations. Steroids. 2008 Aug; 73:708-19. 
6. Livionen S, Hiltunen M, Alafuzoff I, Mannermaa A, 
Kerokoski P, Puoliväli J, et al. Seladin-1 transcription is 
linked to neuronal degeneration in Alzheimer's disease. 
Neuroscince. 2002; 113(2): 301-10. 
7. Peri A, Serio M. Esterogen receptor-mediated 
neuroprotection:The role of the Alzheimer's disease-
related gene seladin-1. Neuropsychiatr Dis Treat. 2008 
Aug; 4(4):817-24. 
8. Lu X, Kambe F, Cao X, Kozaki Y, Kaji T, Ishii T, Seo 
H. DHCR24 is a hydrogen peroxide scavenger, 
protecting cells from oxidative stress-induced apoptosis. 
Endocrinology. 2008; 149:3267-73. 
9. Kuehnle K, Crameri A, Kälin RE, Luciani P, Benvenuti 
S, Peri A, et al. Prosurvival effect of DHCR24/Seladin-1 
in acute and chronic response to oxidative stress. Mol 
Cell Biol. 2008 Jan; 28(2):539-50. 
10. Waterham HR, Koster J, Romeijn GJ, Hennekam RC, 
Vreken P, Andersson HC, et al. Mutations in the 3β-
142                                                                                            Gilanchi et al.                                                    Iran. Biomed. J., July 2014 
 
http://IBJ.pasteur.ac.ir 
hydroxysterol Δ24-reductase gene cause desmosterolosis, 
an autosomal recessive disorder of cholesterol 
biosynthesis. Am J Hum Genet. 2001 Oct; 69:685-94. 
11. Arisp N, Doh M. Plasma membrane cholesterol controls 
the cytotoxicity of Alzheimer's disease AbetaP (1-40) 
AND (1-42) peptides. FASEB J. 2002 Oct; 
16(12):1526-36. 
12. Peri A, Serio M. Neuroprotective effects of the 
Alzheimer's disease-related gene seladin-1.  J Mol 
Endocrinol. 2008 Nov; 41: 251-61. 
13. Takahashi T, Gasch A, Nishizawa N, Chua NH. The 
DIMINUTO gene of Arabidopsis is involved in 
regulating cell elongation. Genes Dev. 1995 Jan; 
9(1):97-107. 
14. Klahre U, Noguchi T, Fujioka S, Takatsuto S, Yokta T, 
Nomura T, et al. The Arabidopsis DIMINUTO/ 
DWARFI gene encodes a protein involved in steroid 
synthesis. Plant Cell. 1998 Oct; 10(10):1677-90. 
15. Lie DC, Song H, Colamarino SA, Ming GL, Gage FH. 
Neurogenesis in the adult brain: new strategies for 
central nervous system diseases. Annu Rev Pharmacol 
Toxicol. 2004; 44:399-421. 
16. Siber-Blum M, Grim M, Hu YF, Szeder V. Pluripotent 
neural creast stem cells in the adult hair follicle. Dev 
Dyn. 2004 Oct; 231(2):258-69. 
17. Siber-Blum M, Grim M. The adult hair follicle: cradle 
for pluripotent neural crest stem cell. Birth Defects Res 
C Embryo Today. 2004 Jun; 72(2):162-72. 
18. Siber-Blum M, Schnell L, Grim M, Hu YF, Schneider 
R, Schwab ME. Characterization of epidermal neural 
crest stem cell (EPI-NCSC) grafts in the lesioned spinal 
cord. Mol Cell Neurosci. 2006 May-Jun; 32(1-2):67-81. 
19. Toma J.G, Akhavan M, Fernandes K.J, Barnabe-Heider 
F, Sadikot A, Kaplan D.R, et al. Isolation of multipotent 
adult stem cells from the dermis of mammalian skin. 
Nat.Cell Boil. 2001 Sep; 3(9):778-84. 
20. Lendhal U, Zimmerman LB, Mckay RD. CNS stem 
cells express a new class of intermediate filament 
protein. Cell. 1990 Feb; 60(4):585-95. 
21. Li L, Mignone J, Yang M, Matic M, Penman S, 
Enikolopov G, et al. Nestin expression in hair follicle 
sheath progenitor cells. Proc Natl Acad Sci USA. 2003 
Aug; 100(17):9958-61. 
22. Amoh Y, Li L, Katsuka K, Hoffma RM. Multipotent 
nestin-expressing hair follicle stem cells. J Dermatol. 
2009 Jan; 36(1):1-9. 
23. Esmaeilzadeh B, Nobakht M, Hosseini SM, Mortazavi 
P, Barati M, Mehrabi S, et al. Adult neurogenesis of 
epidermal neural crest stem cells (EPI-NCSC) in 
hippocampus of Alzheimer's rat model. Comp Clin 
Pathol. 2013 Feb; 22(11):789-97. 
24. Nobakht M, Asalgo S, Rahbar Rooshandel N, 
Mousavizadeh K, Najafzadeh N. Effects of silibinin on 
hair follicle stem cells differentiation to neural-like 
cells. Am J Biotechem Mol Biol. 2011; 1(2):212-22. 
25. Nobakht M, Najafzadeh N, Safari M, Rahbar Roshandel 
N, Delaviz H, Joghataie MT, et al. Bulge cells of rat hair 
follicles: isolation, cultivation, morphological and 
biological features. Yakhteh Med J. 2010; 12(1):51-8. 
26. Amoh Y, Li L, Campillo R, Kawahara K, Katsuoka K, 
Penman S, et al. Implanted hair follicle stem cells form 
Schwann cells that support repair of severed peripheral 
nerves. Proc Natl Acad Sci USA. 2005 Dec; 102(49): 
17734-8. 
27. Luciani P, Ferruzzi P, Arnaldi G, Crescioli C, Benvenuti 
S, Nesi G, et al. Expression of the novel adreno-
corticotropin-responsive gene selective Alzheimer’s 
disease indicator-1 in the normal adrenal cortex and in 
adrenocortical adenomas and carcinomas. J Clin 
Endocrinol Metab. 2004 Mar; 89(3):1332-9. 
28. Amoh Y, Kanoh M, Niiyama S, Kawahara K, Sato Y, 
Katsuaka K, et al. Human and mouse hair follicles 
contain both multipotent and monopotent stem cells. 
Cell Cycle. 2009 Jan; 8(1):176-7. 
29. Ohyama M, Terunuma A, Tock CL, Radonovich MF, 
Pise-Masison CA, Hopping SB, et al. Characterization 
and isolation of stem cell-enriched human hair follicle 
bulge cells. J Clin Invest. 2006 Jan; 116(1):249-260. 
30. Hoffman RM. The pluripotency of hair follicle stem 
cells. Cell Cycle. 2006 Feb; 5(3):232-3. 
31. Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs 
E. Self-renewal, multipotency, and the existence of two 
cell populations within an epithelial stem cell niche. 
Cell. 2004; 118(5):635-48. 
32. Kobayashi K, Rochat A, Barrandon Y. Segregation of 
keratinocyte colony-forming cells in the bulge of the rat 
vibrissae. Proc Natl Acad Sci USA. 1993 Aug; 
90(15):7391-5. 
33. Trempus CS, Morris RJ, Bortner CD, Cotsarelis G, 
Faircloth RS, Reece JM, et al. Enrichment for living 
murine keratinocytes from the hair follicle bulge with 
the cell surface marker CD34. J Invest Dermatol. 2003 
Apr; 120(4):501-11. 
34. Amoh Y, Li L, Katsuoka K, Penman S, Hoffman RM. 
Multipotent-positive, keratin-negative hair-follicle bulge 
stem cells can form neurons. Proc Natl Acad Sci USA 
2005 Apr; 102(15):5530-4. 
35. Amoh Y, Li L, Katsuoka K, Hoffman RM. 
Chemotherapy targets the hair-follicle vascular network 
but not the stem cells. J Invest Dermatol. 2007 Jan; 
127(1):11-5. 
36. Benvenuti S, Saccardi R, Luciani P, Urbani S, Deledda 
C, Cellai I, et al. Neuronal differentiation of human 
mesenchymal stem cells: changes in the expression of 
the Alzheimer’s disease-related gene seladin-1. Exp Cell 
Res. 2006 Aug; 312(13):2592-604. 
 
View publication stats
